Maravai LifeSciences Holdings, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Maravai LifeSciences Holdings, Inc. (MRVI) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $355.59 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $355.59M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $369.08M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $372.71M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $431.86M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $355.59M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $369.08M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $372.71M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $431.86M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $467.98M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $530.27M 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $577.21M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $612.70M 10-Q · filed 2025-11-07 | $613.13M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $772.49M 10-Q · filed 2025-11-07 | $776.41M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $777.39M 10-Q · filed 2025-08-11 | |
| 2023-12-31 | $789.88M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $892.28M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $897.64M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $900.64M 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $905.24M 10-K · filed 2026-02-26 | |
| 2022-09-30 | $841.67M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $773.79M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $654.30M 10-Q · filed 2023-08-08 | |
| 2021-12-31 | $545.36M 10-K · filed 2025-03-18 | |
| 2021-09-30 | $457.20M 10-Q · filed 2022-11-04 | $453.62M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $337.36M 10-Q · filed 2022-11-04 | $333.14M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $213.82M 10-Q · filed 2022-08-05 | $209.76M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $154.75M 10-K · filed 2024-02-29 | |
| 2019-12-31 | $144.63M 10-K · filed 2023-02-28 |